Paul Hudock, MD
Obstetrics & Gynecology · Cleveland, OHNPI 1548210362
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 25.1% of the total. Reporting peaked in 2019 at $725 and has fallen 96.5% since, to $25 in 2023.
Across 54 payments — averaging $18.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$254
- Covidien LP$137
- Therapeuticsmd, Inc.$134
- AMAG Pharmaceuticals, Inc.$81
- Hologic Sales And Service, LLC$65
- Coopersurgical, Inc.$57
- plus $286 from 11 others
What the payments were for
- Food & beverage$93392%
- Education$818%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 13 | $254 |
| Covidien LP | 2 | $137 |
| Therapeuticsmd, Inc. | 8 | $134 |
| AMAG Pharmaceuticals, Inc. | 4 | $81 |
| Hologic Sales And Service, LLC | 5 | $65 |
| Coopersurgical, Inc. | 4 | $57 |
| Merck | 2 | $49 |
| Pfizer | 3 | $43 |
| Amgen | 2 | $36 |
| Exeltis, USA Inc. | 2 | $35 |
| Avion Pharmaceuticals | 2 | $27 |
| Duchesnay USA Incorporated | 2 | $24 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Bayer | 1 | $16 |
| Roche Diagnostics Corporation | 1 | $15 |
| Myovant Sciences Inc. | 1 | $13 |
| Minerva Surgical, Inc | 1 | $11 |
How this compares
$1,014 in reported general payments places this provider in the 60th percentile of 1,376 obstetrics & gynecology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 44 | $2,950 |
| Alendronate Sodium | 25 | $173 |
| Norethindrone Acetate | 13 | $173 |
| Misoprostol | 18 | $32 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Cleveland
- Oluwatosin GojeCleveland$81K
- Jeffrey MangelCleveland$61K
- Julian PeskinCleveland$33K
- Shirley BennettCleveland$25K
- Robert PollardCleveland$16K
- Linda BradleyCleveland$15K
- Alexander KotlyarCleveland$13K
- Kathryn CoyneCleveland$12K
- Samir AhujaMentor$430K
- Burton BrodskySylvania$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.